Supplier profile
Novartis Farmaceutica
Every public-sector award we hold for this supplier, across Spain and Mexico, from 23 Jan 2013 to 10 Oct 2024.
Awards won
456
all time
Attributed value
€4.1m + MXN 11.0bn
3 shared, unvalued
Buyers
7
public bodies
Active
2013–2024
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Servicio Madrileño de la Salud, Hospital Universitario Ramón y Cajal | 4 | €3.5m |
| Comunidad de Madrid; Consejería de Sanidad; Hospital General Universitario Gregorio Marañón | 1 | €147k |
| Consorci de Salut i d'Atenció Social de Catalunya | 1 | not attributable |
| Hospital Universitario Central de Asturias | 1 | not attributable |
| Inspección General de Sanidad de la Defensa | 1 | €212k |
| Servicio Extremeño de Salud; Gerencia del Área de Salud de Badajoz | 1 | €332k |
| Servicio Murciano de Salud | 1 | not attributable |
What they win
Awards
Showing 351–375 of 456 awards we hold
- Inv.23 Req.235 Eco:Sana0098 "Medicinas y Productos Farmacéuticos" ↗£23k
- Licitación Pública Intern. La-006000993-E4-2019 Cons. (Ce-051Gyn007-E1-2020) ↗£269k
- Consolidada de Medicamentos Oncologicos ↗£27.5m
- Adquisición Consolidada de Medicamentos de Patente y Fuente Única ↗£2.0m
- 010.000.5637.00 Eltrombopag 50 Mg. Cada Tableta Contiene Eltrombopag Olamina 50 ↗£76k
- Adquisición de Medicamentos Consolidada 2023-2024 Para Medicamentos de Farmacia Gratuidad ↗£1.5m
- Se03_2020_ Ssa ↗£17.3m
- Adquisicion de Medicinas y Productos Farmaceuticos ↗£66k
- Adquisicion de Medicinas y Productos Farmaceuticos ↗£830k
- Compra Consolidada de Medicamentos y Material de Curación Primer Bloque 2024 ↗£1.7m
- Adquisición Consolidada de 117 Claves de Medicamentos y Bienes Terapéuticos 2022 Fuente Única (Patente Y/O Fuente Única) ↗£13.6m
- Medicamentos y Productos Farmaceuticos ↗£4k
- 010.000.4380.00 Rivastigmina. Parche Cada Parche de 10 Cm2 Contiene Tartrato De ↗£36k
- Dabrafenib 75 Mg. Presentacion: Fco. Con 28 Cap. ↗£357k
- Aa-012M7B998-E6-2022 Medicamentos Insabi ↗£14k
- Aa-050Gyr003-E178-2022 Adquisición de Medicamento de Patente ↗£675k
- Contrataciones Consolidadas de Medicamentos 2023 ↗£183k
- Consolidada de Medicamentos y Bienes Terapeuticos Para el Ejercicio Fiscal 2020 ↗£2.8m
- Adquisición de Medicamentos y Bienes Terapéuticos 2022 ↗£2.5m
- Eltrombopag. Tableta Cada Tableta Contiene: Eltrombopag Olamina Equivalente a 50 ↗£38k
- Medicamentos ↗£35k
- Adquisicion Consolidada de 763 Claves de Medicamentos y 377 de Material de Curacion y Auxiliares de Diagnostico Para el Ejercicio Fiscal 2024 ↗£22.0m
- Aa-012M7B997-E151-2022 Insabi Medicamentos ↗£136.6m
- Adjudicación Directa Intern. No. Aa-051Gyn007-E81-2021, Medicamentos ↗£35.7m
- Licitación Pública Internacional Bct Electrónica La-012M7B997-E115-2022 Cons. (Ce-051Gyn007-E67-2022) ↗£143k
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.